共 35 条
- [28] Blinatumomab-induced lineage switch of B-ALL with t(4:11) (q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis BLOOD CANCER JOURNAL, 2017, 7 : e607 - e607
- [29] Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis Blood Cancer Journal, 2017, 7 : e607 - e607
- [30] Hsa-mir-125b-2 is Highly Expressed in Childhood ETV6/RUNX1 (TEL/AML 1) Leukemias and Confers Survival Advantage to Growth Inhibitory Signals Independent of P53 KLINISCHE PADIATRIE, 2011, 223 (01): : 53 - 53